Floatz logo

.Alpha.-1 Protease Inhibitor

Type 1 Diabetes Mellitus

Grifols Therapeutics LLCprotein_peptidePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Type 1 Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Heba M. Ismail
Phase 4A
Liraglutide
Dasman Diabetes Institute
Phase 4BBB
Tirzepatide
Royal North Shore Hospital
Phase 4BBB
Semaglutide
Nordsjaellands Hospital
Phase 3BB
ct-868
Carmot Therapeutics, Inc.
Phase 2BB

View all 21 →

Same molecule, other indications

.Alpha.-1 Protease Inhibitor is also rated in:

alpha 1-antitrypsin deficiencyActive
A
Indicative · Phase 4
81 / 100
View asset →
chronic obstructive pulmonary diseaseActive
BB
Indicative · Phase 4
65 / 100
View asset →
pulmonary emphysemaActive
B
Indicative · Phase 2
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →